Cebiotex Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.72M

  • Investors
  • 6

Cebiotex General Information

Description

Developer of electrospun nanofiber technology designed to help clients in the local treatment of unresectable cancer tumors. The company's electrospun nanofiber technology has developed in vitro and in vivo and preclinical nonwoven nanofiber membranes for the controlled release of active agents, enabling medical professionals to treat unresectable cancer tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Corporate Office
  • Via Laietana, 26
  • Tech Barcelona Pier 07, Mezzanine
  • 08003 Barcelona
  • Spain

Cebiotex Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cebiotex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 24-Sep-2021 $4.72M 000.00 00.00 Completed Generating Revenue
10. Equity Crowdfunding 22-Dec-2020 00000 00.000 000.00 Completed Generating Revenue
9. Seed Round 10-Feb-2020 00.00 00.000 00.000 Completed Generating Revenue
8. Seed Round 16-Feb-2017 00.000 00.000 00.000 Completed Generating Revenue
7. Grant 12-Dec-2016 000.00 00.000 Completed Generating Revenue
6. Equity Crowdfunding 31-May-2016 00000 00.000 00.000 Completed Startup
5. Equity Crowdfunding 00000 00.000 Completed Startup
4. Seed Round 27-Feb-2015 00000 00.00 00.000 Completed Startup
3. Seed Round 19-Nov-2013 $1.83M $1.83M Completed Startup
2. Accelerator/Incubator 19-Nov-2013 $4.07K $4.07K Completed Startup
To view Cebiotex’s complete valuation and funding history, request access »

Cebiotex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 2,837 $1.179683 $551.77 $551.77 1x $551.77 21.42%
Ordinary 1,276 $1.179683 $255.66 $255.66 1x $255.66 9.63%
To view Cebiotex’s complete cap table history, request access »

Cebiotex Patents

Cebiotex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2935179-T3 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018 0000000000
US-20210154151-A1 Beaded nonwoven membrane as a drug delivery system Pending 03-Aug-2018 00000000
EP-3829549-B1 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018 00000000
EP-3829549-A1 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018 A61K9/7007

Cebiotex Executive Team (7)

Name Title Board Seat Contact Info
Joan Llavina Co-Founder, Chief Executive Officer and President
Luc Marti Ph.D Chief Operating Officer
Jose Tornero Ph.D Chief Technology Officer & Co-Founder
Imma Turro Chief Business Officer
Lucas Krauel Ph.D Co-Founder, Chief Surgical Officer & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Cebiotex Board Members (7)

Name Representing Role Since
Antonio Villaró Self Board Member 000 0000
Carolina La Valle Self Board Member 000 0000
Emili Bargalló Self Board Member 000 0000
Lucas Krauel Ph.D Cebiotex Co-Founder, Chief Surgical Officer & Board Member 000 0000
Marc Ramis Castelltort Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cebiotex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cebiotex Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Inveready Asset Management Venture Capital Minority 000 0000 000000 0
Ship2B Accelerator/Incubator Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Barcelona Activa Accelerator/Incubator Minority 000 0000 000000 0
Biocat Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Cebiotex FAQs

  • When was Cebiotex founded?

    Cebiotex was founded in 2012.

  • Who is the founder of Cebiotex?

    Joan Llavina, Jose Tornero Ph.D, Lucas Krauel Ph.D, and Jaume Mora Ph.D are the founders of Cebiotex.

  • Who is the CEO of Cebiotex?

    Joan Llavina is the CEO of Cebiotex.

  • Where is Cebiotex headquartered?

    Cebiotex is headquartered in Barcelona, Spain.

  • What is the size of Cebiotex?

    Cebiotex has 6 total employees.

  • What industry is Cebiotex in?

    Cebiotex’s primary industry is Discovery Tools (Healthcare).

  • Is Cebiotex a private or public company?

    Cebiotex is a Private company.

  • What is the current valuation of Cebiotex?

    The current valuation of Cebiotex is 00.00.

  • What is Cebiotex’s current revenue?

    The current revenue for Cebiotex is 00000.

  • How much funding has Cebiotex raised over time?

    Cebiotex has raised $11.9M.

  • Who are Cebiotex’s investors?

    Inveready Asset Management, Ship2B, Horizon 2020 SME Instrument, Barcelona Activa, and Biocat are 5 of 6 investors who have invested in Cebiotex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »